| Literature DB >> 33672786 |
Jennifer Chun Yu1, Mario Mietzsch1, Amriti Singh1, Alberto Jimenez Ybargollin1, Shweta Kailasan1, Paul Chipman1, Nilakshee Bhattacharya2, Julia Fakhiri3, Dirk Grimm3, Amit Kapoor4, Indrė Kučinskaitė-Kodzė5, Aurelija Žvirblienė5, Maria Söderlund-Venermo6, Robert McKenna1, Mavis Agbandje-McKenna1.
Abstract
Human bocavirus 1 (HBoV1) has gained attention as a gene delivery vector with its ability to infect polarized human airway epithelia and 5.5 kb genome packaging capacity. Gorilla bocavirus 1 (GBoV1) VP3 shares 86% amino acid sequence identity with HBoV1 but has better transduction efficiency in several human cell types. Here, we report the capsid structure of GBoV1 determined to 2.76 Å resolution using cryo-electron microscopy (cryo-EM) and its interaction with mouse monoclonal antibodies (mAbs) and human sera. GBoV1 shares capsid surface morphologies with other parvoviruses, with a channel at the 5-fold symmetry axis, protrusions surrounding the 3-fold axis and a depression at the 2-fold axis. A 2/5-fold wall separates the 2-fold and 5-fold axes. Compared to HBoV1, differences are localized to the 3-fold protrusions. Consistently, native dot immunoblots and cryo-EM showed cross-reactivity and binding, respectively, by a 5-fold targeted HBoV1 mAb, 15C6. Surprisingly, recognition was observed for one out of three 3-fold targeted mAbs, 12C1, indicating some structural similarity at this region. In addition, GBoV1, tested against 40 human sera, showed the similar rates of seropositivity as HBoV1. Immunogenic reactivity against parvoviral vectors is a significant barrier to efficient gene delivery. This study is a step towards optimizing bocaparvovirus vectors with antibody escape properties.Entities:
Keywords: antigenicity; bocavirus; capsid; cryo-EM; gene therapy; parvovirus
Mesh:
Substances:
Year: 2021 PMID: 33672786 PMCID: PMC7924616 DOI: 10.3390/v13020330
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.818